Filing Details

Accession Number:
0001209191-11-058590
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-30 20:32:28
Reporting Period:
2011-11-28
Filing Date:
2011-11-30
Accepted Time:
2011-11-30 20:32:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
827809 Qlt Inc QLTI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1369220 R Alexander Lussow C/O Qlt Inc.
887 Great Northern Way, Suite 101
Vancouver A1 V5T 4T5
Sr. Vp, Bus. Dev. & Comm. Op. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-28 5,600 $3.61 25,600 No 4 M Direct
Common Stock Disposition 2011-11-28 5,600 $7.03 20,000 No 4 S Direct
Common Stock Acquisiton 2011-11-29 24,400 $3.62 44,400 No 4 M Direct
Common Stock Disposition 2011-11-29 4,400 $6.85 40,000 No 4 S Direct
Common Stock Disposition 2011-11-29 20,000 $6.73 20,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (right to buy) Disposition 2011-11-28 5,600 $0.00 5,600 $3.61
Common Stock Employee Stock Options (right to buy) Disposition 2011-11-29 24,400 $0.00 24,400 $3.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
144,400 2013-05-17 No 4 M Direct
120,000 2013-05-17 No 4 M Direct
Footnotes
  1. Price reflects the conversion of Canadian dollars to U.S. dollars based on the exchange rate in effect as of the date of reportable event.
  2. This transaction was executed in multiple trades in prices ranging from $6.9924 to $7.0379 (after reflecting the conversion of Canadian dollars to U.S. dollars). The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades in prices ranging from $6.8153 to $6.9415 (after reflecting the conversion of Canadian dollars to U.S. dollars). The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades in prices ranging from $6.69 to $6.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  5. The option vests in 36 equal monthly installments, beginning on June 17, 2008.